TraceLink Lands $51,500,000 Series C Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a08abcec-2146-47b2-8834-3744c2cf2e9a - Date
12/1/2016 - Company Name
TraceLink - Mailing Address
200 Quannapowitt Parkway Wakefield, MA 01880 USA - Company Description
TraceLink protects patients, enables health, grows profits and ensures compliance for companies across the global Life Sciences network through the TraceLink Life Sciences Cloud. - Website
http://www.tracelink.com - Transaction Type
Venture Equity - Transaction Amount
$51,500,000 - Transaction Round
Series C - Proceeds Purposes
This investment will enable TraceLink to improve its position in the global pharmaceutical track and trace industry, providing manufacturers, distributors and dispensers with a cost-effective solution to secure the drug supply chain and protect patients from counterfeit medicines, a problem that causes hundreds of thousands of deaths and leads to an estimated $75 billion in lost industry revenue each year. - M&A Terms
- Venture Investor
Goldman Sachs - Venture Investor
FirstMark Capital - Venture Investor
Volition Capital - Venture Investor
F-Prime Capital
